[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Market Report 2016

November 2016 | 114 pages | ID: E775D097FD4EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Pulmonary Arterial Hypertension (PAH) Therapeutics

Revenue, means the sales value of Pulmonary Arterial Hypertension (PAH) Therapeutics

This report studies sales (consumption) of Pulmonary Arterial Hypertension (PAH) Therapeutics in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
  • Actelion Pharmaceuticals Ltd. (Switzerland)
  • Arena Pharmaceuticals, Inc. (US)
  • Bayer HealthCare Pharmaceuticals (Germany)
  • Cipla Limited (India)
  • Daiichi Sankyo Co., Ltd. (Japan)
  • Eli Lilly and Company (US)
  • Gilead Sciences, Inc. (US)
  • GlaxoSmithKline Plc (UK)
  • Nippon Shinyaku Co., Ltd. (Japan)
  • Pfizer, Inc. (US)
  • Sanofi S.A (France)
  • The Novartis Group (Switzerland)
  • United Therapeutics Corp. (US)
  • YM BioSciences, Inc. (Canada)
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Pulmonary Arterial Hypertension (PAH) Therapeutics in these countries, from 2011 to 2021 (forecast), like
  • Germany
  • France
  • UK
  • Russia
  • Italy
  • Spain
  • Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by application, this report focuses on sales, market share and growth rate of Pulmonary Arterial Hypertension (PAH) Therapeutics in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Market Report 2016

1 PULMONARY ARTERIAL HYPERTENSION (PAH) THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Pulmonary Arterial Hypertension (PAH) Therapeutics
1.2 Classification of Pulmonary Arterial Hypertension (PAH) Therapeutics
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Pulmonary Arterial Hypertension (PAH) Therapeutics
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Pulmonary Arterial Hypertension (PAH) Therapeutics Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Pulmonary Arterial Hypertension (PAH) Therapeutics (2011-2021)
  1.5.1 Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Growth Rate (2011-2021)
  1.5.2 Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate (2011-2021)

2 EUROPE PULMONARY ARTERIAL HYPERTENSION (PAH) THERAPEUTICS BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Market Competition by Manufacturers
  2.1.1 Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Pulmonary Arterial Hypertension (PAH) Therapeutics (Volume and Value) by Type
  2.2.1 Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Market Share by Type (2011-2016)
2.3 Europe Pulmonary Arterial Hypertension (PAH) Therapeutics (Volume and Value) by Countries
  2.3.1 Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Market Share by Countries (2011-2016)
2.4 Europe Pulmonary Arterial Hypertension (PAH) Therapeutics (Volume) by Application

3 GERMANY PULMONARY ARTERIAL HYPERTENSION (PAH) THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Value (2011-2016)
  3.1.1 Germany Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Growth Rate (2011-2016)
  3.1.2 Germany Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Price Trend (2011-2016)
3.2 Germany Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Market Share by Manufacturers
3.3 Germany Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Market Share by Type
3.4 Germany Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Market Share by Application

4 FRANCE PULMONARY ARTERIAL HYPERTENSION (PAH) THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

4.1 France Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Value (2011-2016)
  4.1.1 France Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Growth Rate (2011-2016)
  4.1.2 France Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate (2011-2016)
  4.1.4 France Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Price Trend (2011-2016)
4.2 France Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Market Share by Manufacturers
4.3 France Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Market Share by Type
4.4 France Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Market Share by Application

5 UK PULMONARY ARTERIAL HYPERTENSION (PAH) THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

5.1 UK Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Value (2011-2016)
  5.1.1 UK Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Growth Rate (2011-2016)
  5.1.2 UK Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate (2011-2016)
  5.1.5 UK Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Price Trend (2011-2016)
5.2 UK Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Market Share by Manufacturers
5.3 UK Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Market Share by Type
5.4 UK Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Market Share by Application

6 RUSSIA PULMONARY ARTERIAL HYPERTENSION (PAH) THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Value (2011-2016)
  6.1.1 Russia Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Growth Rate (2011-2016)
  6.1.2 Russia Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Price Trend (2011-2016)
6.2 Russia Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Market Share by Manufacturers
6.3 Russia Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Market Share by Type
6.4 Russia Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Market Share by Application

7 ITALY PULMONARY ARTERIAL HYPERTENSION (PAH) THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Value (2011-2016)
  7.1.1 Italy Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Growth Rate (2011-2016)
  7.1.2 Italy Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Price Trend (2011-2016)
7.2 Italy Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Market Share by Manufacturers
7.3 Italy Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Market Share by Type
7.4 Italy Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Market Share by Application

8 SPAIN PULMONARY ARTERIAL HYPERTENSION (PAH) THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Value (2011-2016)
  8.1.1 Spain Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Growth Rate (2011-2016)
  8.1.2 Spain Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Price Trend (2011-2016)
8.2 Spain Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Market Share by Manufacturers
8.3 Spain Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Market Share by Type
8.4 Spain Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Market Share by Application

9 BENELUX PULMONARY ARTERIAL HYPERTENSION (PAH) THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Value (2011-2016)
  9.1.1 Benelux Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Price Trend (2011-2016)
9.2 Benelux Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Market Share by Manufacturers
9.3 Benelux Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Market Share by Type
9.4 Benelux Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Market Share by Application

10 EUROPE PULMONARY ARTERIAL HYPERTENSION (PAH) THERAPEUTICS MANUFACTURERS ANALYSIS

10.1 Actelion Pharmaceuticals Ltd. (Switzerland)
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Actelion Pharmaceuticals Ltd. (Switzerland) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Arena Pharmaceuticals, Inc. (US)
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Arena Pharmaceuticals, Inc. (US) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Bayer HealthCare Pharmaceuticals (Germany)
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Bayer HealthCare Pharmaceuticals (Germany) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Cipla Limited (India)
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Cipla Limited (India) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Daiichi Sankyo Co., Ltd. (Japan)
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Daiichi Sankyo Co., Ltd. (Japan) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Eli Lilly and Company (US)
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Eli Lilly and Company (US) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Gilead Sciences, Inc. (US)
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Gilead Sciences, Inc. (US) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 GlaxoSmithKline Plc (UK)
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 GlaxoSmithKline Plc (UK) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 Nippon Shinyaku Co., Ltd. (Japan)
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Product Type, Application and Specification
    10.9.2.1 Type I
    10.9.2.2 Type II
  10.9.3 Nippon Shinyaku Co., Ltd. (Japan) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 Pfizer, Inc. (US)
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Product Type, Application and Specification
    10.10.2.1 Type I
    10.10.2.2 Type II
  10.10.3 Pfizer, Inc. (US) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview
10.11 Sanofi S.A (France)
10.12 The Novartis Group (Switzerland)
10.13 United Therapeutics Corp. (US)
10.14 YM BioSciences, Inc. (Canada)

11 PULMONARY ARTERIAL HYPERTENSION (PAH) THERAPEUTICS MANUFACTURING COST ANALYSIS

11.1 Pulmonary Arterial Hypertension (PAH) Therapeutics Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Pulmonary Arterial Hypertension (PAH) Therapeutics

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Pulmonary Arterial Hypertension (PAH) Therapeutics Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Pulmonary Arterial Hypertension (PAH) Therapeutics Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE PULMONARY ARTERIAL HYPERTENSION (PAH) THERAPEUTICS MARKET FORECAST (2016-2021)

14.1 Germany Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Forecast (2016-2021)
14.2 France Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Forecast (2016-2021)
14.3 UK Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Forecast (2016-2021)
14.4 Russia Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Forecast (2016-2021)
14.5 Italy Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Forecast (2016-2021)
14.6 Spain Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Forecast (2016-2021)
14.7 Benelux Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Forecast (2016-2021)
14.8 Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Forecast by Type (2016-2021)
14.9 Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Pulmonary Arterial Hypertension (PAH) Therapeutics
Table Classification of Pulmonary Arterial Hypertension (PAH) Therapeutics
Figure Europe Sales Market Share of Pulmonary Arterial Hypertension (PAH) Therapeutics by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Pulmonary Arterial Hypertension (PAH) Therapeutics
Figure Europe Sales Market Share of Pulmonary Arterial Hypertension (PAH) Therapeutics by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate (2011-2021)
Figure France Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate (2011-2021)
Figure UK Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate (2011-2021)
Figure Russia Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate (2011-2021)
Figure Italy Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate (2011-2021)
Figure Spain Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate (2011-2021)
Figure Benelux Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate (2011-2021)
Figure Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Growth Rate (2011-2021)
Figure Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate (2011-2021)
Table Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Sales of Key Manufacturers (2015 and 2016)
Table Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Share by Manufacturers
Figure 2016 Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Share by Manufacturers
Table Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue by Manufacturers (2015 and 2016)
Table Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue Share by Manufacturers
Table 2016 Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue Share by Manufacturers
Table Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Market Share by Type (2011-2016)
Table Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Share by Type (2011-2016)
Figure Sales Market Share of Pulmonary Arterial Hypertension (PAH) Therapeutics by Type (2011-2016)
Figure Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Growth Rate by Type (2011-2016)
Table Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Market Share by Type (2011-2016)
Table Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Pulmonary Arterial Hypertension (PAH) Therapeutics by Type (2011-2016)
Figure Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue Growth Rate by Type (2011-2016)
Table Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Market Share by Countries (2011-2016)
Table Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Share by Countries (2011-2016)
Figure Sales Market Share of Pulmonary Arterial Hypertension (PAH) Therapeutics by Countries (2011-2016)
Table Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Market Share by Countries (2011-2016)
Table Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Pulmonary Arterial Hypertension (PAH) Therapeutics by Countries (2011-2016)
Table Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Market Share by Application (2011-2016)
Table Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Share by Application (2011-2016)
Figure Sales Market Share of Pulmonary Arterial Hypertension (PAH) Therapeutics by Application (2011-2016)
Figure Germany Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Growth Rate (2011-2016)
Figure Germany Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate (2011-2016)
Figure Germany Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Price Trend (2011-2016)
Table Germany Pulmonary Arterial Hypertension (PAH) Therapeutics Sales by Manufacturers (2015 and 2016)
Table Germany Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share by Manufacturers (2015 and 2016)
Table Germany Pulmonary Arterial Hypertension (PAH) Therapeutics Sales by Type (2015 and 2016)
Table Germany Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share by Type (2015 and 2016)
Table Germany Pulmonary Arterial Hypertension (PAH) Therapeutics Sales by Application (2015 and 2016)
Table Germany Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share by Application (2015 and 2016)
Figure France Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Growth Rate (2011-2016)
Figure France Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate (2011-2016)
Figure France Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Price Trend (2011-2016)
Table France Pulmonary Arterial Hypertension (PAH) Therapeutics Sales by Manufacturers (2015 and 2016)
Table France Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share by Manufacturers (2015 and 2016)
Table France Pulmonary Arterial Hypertension (PAH) Therapeutics Sales by Type (2015 and 2016)
Table France Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share by Type (2015 and 2016)
Table France Pulmonary Arterial Hypertension (PAH) Therapeutics Sales by Application (2015 and 2016)
Table France Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share by Application (2015 and 2016)
Figure UK Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Growth Rate (2011-2016)
Figure UK Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate (2011-2016)
Figure UK Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Price Trend (2011-2016)
Table UK Pulmonary Arterial Hypertension (PAH) Therapeutics Sales by Manufacturers (2015 and 2016)
Table UK Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share by Manufacturers (2015 and 2016)
Table UK Pulmonary Arterial Hypertension (PAH) Therapeutics Sales by Type (2015 and 2016)
Table UK Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share by Type (2015 and 2016)
Table UK Pulmonary Arterial Hypertension (PAH) Therapeutics Sales by Application (2015 and 2016)
Table UK Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share by Application (2015 and 2016)
Figure Russia Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Growth Rate (2011-2016)
Figure Russia Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate (2011-2016)
Figure Russia Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Price Trend (2011-2016)
Table Russia Pulmonary Arterial Hypertension (PAH) Therapeutics Sales by Manufacturers (2015 and 2016)
Table Russia Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share by Manufacturers (2015 and 2016)
Table Russia Pulmonary Arterial Hypertension (PAH) Therapeutics Sales by Type (2015 and 2016)
Table Russia Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share by Type (2015 and 2016)
Table Russia Pulmonary Arterial Hypertension (PAH) Therapeutics Sales by Application (2015 and 2016)
Table Russia Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share by Application (2015 and 2016)
Figure Italy Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Growth Rate (2011-2016)
Figure Italy Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate (2011-2016)
Figure Italy Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Price Trend (2011-2016)
Table Italy Pulmonary Arterial Hypertension (PAH) Therapeutics Sales by Manufacturers (2015 and 2016)
Table Italy Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share by Manufacturers (2015 and 2016)
Table Italy Pulmonary Arterial Hypertension (PAH) Therapeutics Sales by Type (2015 and 2016)
Table Italy Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share by Type (2015 and 2016)
Table Italy Pulmonary Arterial Hypertension (PAH) Therapeutics Sales by Application (2015 and 2016)
Table Italy Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share by Application (2015 and 2016)
Figure Spain Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Growth Rate (2011-2016)
Figure Spain Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate (2011-2016)
Figure Spain Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Price Trend (2011-2016)
Table Spain Pulmonary Arterial Hypertension (PAH) Therapeutics Sales by Manufacturers (2015 and 2016)
Table Spain Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share by Manufacturers (2015 and 2016)
Table Spain Pulmonary Arterial Hypertension (PAH) Therapeutics Sales by Type (2015 and 2016)
Table Spain Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share by Type (2015 and 2016)
Table Spain Pulmonary Arterial Hypertension (PAH) Therapeutics Sales by Application (2015 and 2016)
Table Spain Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share by Application (2015 and 2016)
Figure Benelux Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Growth Rate (2011-2016)
Figure Benelux Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate (2011-2016)
Figure Benelux Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Price Trend (2011-2016)
Table Benelux Pulmonary Arterial Hypertension (PAH) Therapeutics Sales by Manufacturers (2015 and 2016)
Table Benelux Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share by Manufacturers (2015 and 2016)
Table Benelux Pulmonary Arterial Hypertension (PAH) Therapeutics Sales by Type (2015 and 2016)
Table Benelux Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share by Type (2015 and 2016)
Table Benelux Pulmonary Arterial Hypertension (PAH) Therapeutics Sales by Application (2015 and 2016)
Table Benelux Pulmonary Arterial Hypertension (PAH) Therapeutics Market Share by Application (2015 and 2016)
Table Pulmonary Arterial Hypertension (PAH) Therapeutics Basic Information List
Table Actelion Pharmaceuticals Ltd. (Switzerland) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Actelion Pharmaceuticals Ltd. (Switzerland) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Market Share (2011-2016)
Table Arena Pharmaceuticals, Inc. (US) Basic Information List
Table Arena Pharmaceuticals, Inc. (US) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Arena Pharmaceuticals, Inc. (US) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Market Share (2011-2016)
Table Bayer HealthCare Pharmaceuticals (Germany) Basic Information List
Table Bayer HealthCare Pharmaceuticals (Germany) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer HealthCare Pharmaceuticals (Germany) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Market Share (2011-2016)
Table Cipla Limited (India) Basic Information List
Table Cipla Limited (India) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cipla Limited (India) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Market Share (2011-2016)
Table Daiichi Sankyo Co., Ltd. (Japan) Basic Information List
Table Daiichi Sankyo Co., Ltd. (Japan) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Daiichi Sankyo Co., Ltd. (Japan) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Market Share (2011-2016)
Table Eli Lilly and Company (US) Basic Information List
Table Eli Lilly and Company (US) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly and Company (US) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Market Share (2011-2016)
Table Gilead Sciences, Inc. (US) Basic Information List
Table Gilead Sciences, Inc. (US) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gilead Sciences, Inc. (US) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc (UK) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Market Share (2011-2016)
Table Nippon Shinyaku Co., Ltd. (Japan) Basic Information List
Table Nippon Shinyaku Co., Ltd. (Japan) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Nippon Shinyaku Co., Ltd. (Japan) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Market Share (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer, Inc. (US) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Market Share (2011-2016)
Table Sanofi S.A (France) Basic Information List
Table Sanofi S.A (France) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A (France) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Market Share (2011-2016)
Table The Novartis Group (Switzerland) Basic Information List
Table The Novartis Group (Switzerland) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table The Novartis Group (Switzerland) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Market Share (2011-2016)
Table United Therapeutics Corp. (US) Basic Information List
Table United Therapeutics Corp. (US) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table United Therapeutics Corp. (US) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Market Share (2011-2016)
Table YM BioSciences, Inc. (Canada) Basic Information List
Table YM BioSciences, Inc. (Canada) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table YM BioSciences, Inc. (Canada) Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pulmonary Arterial Hypertension (PAH) Therapeutics
Figure Manufacturing Process Analysis of Pulmonary Arterial Hypertension (PAH) Therapeutics
Figure Pulmonary Arterial Hypertension (PAH) Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Pulmonary Arterial Hypertension (PAH) Therapeutics Major Manufacturers in 2015
Table Major Buyers of Pulmonary Arterial Hypertension (PAH) Therapeutics
Table Distributors/Traders List
Figure Germany Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Growth Rate Forecast (2016-2021)
Figure Germany Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Figure France Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Growth Rate Forecast (2016-2021)
Figure France Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Figure UK Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Growth Rate Forecast (2016-2021)
Figure UK Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Growth Rate Forecast (2016-2021)
Figure Russia Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Growth Rate Forecast (2016-2021)
Figure Italy Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Growth Rate Forecast (2016-2021)
Figure Spain Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Pulmonary Arterial Hypertension (PAH) Therapeutics Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Pulmonary Arterial Hypertension (PAH) Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Table Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Forecast by Type (2016-2021)
Table Europe Pulmonary Arterial Hypertension (PAH) Therapeutics Sales Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories